- REPORT SUMMARY
- TABLE OF CONTENTS
-
To calculate the market size, the report considers revenue generated from the sales of branded therapies derived from the various fractions of plasma such as albumin, immunoglobulins, coagulation factors, hyperimmune globulins, and A1PI.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Plasma Therapeutics market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Plasma Therapeutics market. Detailed analysis of key players, along with key growth strategies adopted by Plasma Therapeutics industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
China Biologic Products
BioDelivery Sciences
Grifols Therapeutics
Octapharma
Biotest Pharmaceuticals
Baxter
ADMA Biologics
CSL Behring
Biota Pharmaceuticals
Bio Products Laboratory
Amag Pharmaceuticals
Abeona Therapeutics
Antares Pharma
By Type:
Human Serum Protein
Plasma-Derived Clotting Factor
Immunoglobulins
High Immunoglobulins
By End-User:
Research Laboratories And Institutions
Hospitals
Stand-Alone Blood Banks
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Plasma Therapeutics Market
-
1.3 Market Segment by Type
-
1.3.1 China Plasma Therapeutics Market Size and Growth Rate of Human Serum Protein from 2016 to 2027
-
1.3.2 China Plasma Therapeutics Market Size and Growth Rate of Plasma-Derived Clotting Factor from 2016 to 2027
-
1.3.3 China Plasma Therapeutics Market Size and Growth Rate of Immunoglobulins from 2016 to 2027
-
1.3.4 China Plasma Therapeutics Market Size and Growth Rate of High Immunoglobulins from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Plasma Therapeutics Market Size and Growth Rate of Research Laboratories And Institutions from 2016 to 2027
-
1.4.2 China Plasma Therapeutics Market Size and Growth Rate of Hospitals from 2016 to 2027
-
1.4.3 China Plasma Therapeutics Market Size and Growth Rate of Stand-Alone Blood Banks from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Plasma Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Plasma Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Plasma Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Plasma Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Plasma Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Plasma Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Plasma Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Plasma Therapeutics Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Plasma Therapeutics by Major Types
-
3.4.1 Market Size and Growth Rate of Human Serum Protein
-
3.4.2 Market Size and Growth Rate of Plasma-Derived Clotting Factor
-
3.4.3 Market Size and Growth Rate of Immunoglobulins
-
3.4.4 Market Size and Growth Rate of High Immunoglobulins
4 Segmentation of Plasma Therapeutics Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Plasma Therapeutics by Major End-Users
-
4.4.1 Market Size and Growth Rate of Plasma Therapeutics in Research Laboratories And Institutions
-
4.4.2 Market Size and Growth Rate of Plasma Therapeutics in Hospitals
-
4.4.3 Market Size and Growth Rate of Plasma Therapeutics in Stand-Alone Blood Banks
5 Market Analysis by Regions
-
5.1 China Plasma Therapeutics Production Analysis by Regions
-
5.2 China Plasma Therapeutics Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Plasma Therapeutics Landscape Analysis
-
6.1 North China Plasma Therapeutics Landscape Analysis by Major Types
-
6.2 North China Plasma Therapeutics Landscape Analysis by Major End-Users
7 Central China Plasma Therapeutics Landscape Analysis
-
7.1 Central China Plasma Therapeutics Landscape Analysis by Major Types
-
7.2 Central China Plasma Therapeutics Landscape Analysis by Major End-Users
8 South China Plasma Therapeutics Landscape Analysis
-
8.1 South China Plasma Therapeutics Landscape Analysis by Major Types
-
8.2 South China Plasma Therapeutics Landscape Analysis by Major End-Users
9 East China Plasma Therapeutics Landscape Analysis
-
9.1 East China Plasma Therapeutics Landscape Analysis by Major Types
-
9.2 East China Plasma Therapeutics Landscape Analysis by Major End-Users
10 Northeast China Plasma Therapeutics Landscape Analysis
-
10.1 Northeast China Plasma Therapeutics Landscape Analysis by Major Types
-
10.2 Northeast China Plasma Therapeutics Landscape Analysis by Major End-Users
11 Southwest China Plasma Therapeutics Landscape Analysis
-
11.1 Southwest China Plasma Therapeutics Landscape Analysis by Major Types
-
11.2 Southwest China Plasma Therapeutics Landscape Analysis by Major End-Users
12 Northwest China Plasma Therapeutics Landscape Analysis
-
12.1 Northwest China Plasma Therapeutics Landscape Analysis by Major Types
-
12.2 Northwest China Plasma Therapeutics Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 China Biologic Products
-
13.1.1 China Biologic Products Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 BioDelivery Sciences
-
13.2.1 BioDelivery Sciences Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Grifols Therapeutics
-
13.3.1 Grifols Therapeutics Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Octapharma
-
13.4.1 Octapharma Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Biotest Pharmaceuticals
-
13.5.1 Biotest Pharmaceuticals Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Baxter
-
13.6.1 Baxter Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 ADMA Biologics
-
13.7.1 ADMA Biologics Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 CSL Behring
-
13.8.1 CSL Behring Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 Biota Pharmaceuticals
-
13.9.1 Biota Pharmaceuticals Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
-
13.10 Bio Products Laboratory
-
13.10.1 Bio Products Laboratory Company Profile and Recent Development
-
13.10.2 Market Performance
-
13.10.3 Product and Service Introduction
-
13.11 Amag Pharmaceuticals
-
13.11.1 Amag Pharmaceuticals Company Profile and Recent Development
-
13.11.2 Market Performance
-
13.11.3 Product and Service Introduction
-
13.12 Abeona Therapeutics
-
13.12.1 Abeona Therapeutics Company Profile and Recent Development
-
13.12.2 Market Performance
-
13.12.3 Product and Service Introduction
-
13.13 Antares Pharma
-
13.13.1 Antares Pharma Company Profile and Recent Development
-
13.13.2 Market Performance
-
13.13.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Plasma Therapeutics Market Size and Growth Rate of Human Serum Protein from 2016 to 2027
-
Figure China Plasma Therapeutics Market Size and Growth Rate of Plasma-Derived Clotting Factor from 2016 to 2027
-
Figure China Plasma Therapeutics Market Size and Growth Rate of Immunoglobulins from 2016 to 2027
-
Figure China Plasma Therapeutics Market Size and Growth Rate of High Immunoglobulins from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Plasma Therapeutics Market Size and Growth Rate of Research Laboratories And Institutions from 2016 to 2027
-
Figure China Plasma Therapeutics Market Size and Growth Rate of Hospitals from 2016 to 2027
-
Figure China Plasma Therapeutics Market Size and Growth Rate of Stand-Alone Blood Banks from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Plasma Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Plasma Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Plasma Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Plasma Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Plasma Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Plasma Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Plasma Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Plasma Therapeutics Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Plasma Therapeutics
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Plasma Therapeutics by Different Types from 2016 to 2027
-
Table Consumption Share of Plasma Therapeutics by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Human Serum Protein
-
Figure Market Size and Growth Rate of Plasma-Derived Clotting Factor
-
Figure Market Size and Growth Rate of Immunoglobulins
-
Figure Market Size and Growth Rate of High Immunoglobulins
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Plasma Therapeutics by Different End-Users from 2016 to 2027
-
Table Consumption Share of Plasma Therapeutics by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Research Laboratories And Institutions
-
Figure Market Size and Growth Rate of Hospitals
-
Figure Market Size and Growth Rate of Stand-Alone Blood Banks
-
Table China Plasma Therapeutics Production by Regions
-
Table China Plasma Therapeutics Production Share by Regions
-
Figure China Plasma Therapeutics Production Share by Regions in 2016
-
Figure China Plasma Therapeutics Production Share by Regions in 2021
-
Figure China Plasma Therapeutics Production Share by Regions in 2027
-
Table China Plasma Therapeutics Consumption by Regions
-
Table China Plasma Therapeutics Consumption Share by Regions
-
Figure China Plasma Therapeutics Consumption Share by Regions in 2016
-
Figure China Plasma Therapeutics Consumption Share by Regions in 2021
-
Figure China Plasma Therapeutics Consumption Share by Regions in 2027
-
Table North China Plasma Therapeutics Consumption by Types from 2016 to 2027
-
Table North China Plasma Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure North China Plasma Therapeutics Consumption Share by Types in 2016
-
Figure North China Plasma Therapeutics Consumption Share by Types in 2021
-
Figure North China Plasma Therapeutics Consumption Share by Types in 2027
-
Table North China Plasma Therapeutics Consumption by End-Users from 2016 to 2027
-
Table North China Plasma Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure North China Plasma Therapeutics Consumption Share by End-Users in 2016
-
Figure North China Plasma Therapeutics Consumption Share by End-Users in 2021
-
Figure North China Plasma Therapeutics Consumption Share by End-Users in 2027
-
Table Central China Plasma Therapeutics Consumption by Types from 2016 to 2027
-
Table Central China Plasma Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure Central China Plasma Therapeutics Consumption Share by Types in 2016
-
Figure Central China Plasma Therapeutics Consumption Share by Types in 2021
-
Figure Central China Plasma Therapeutics Consumption Share by Types in 2027
-
Table Central China Plasma Therapeutics Consumption by End-Users from 2016 to 2027
-
Table Central China Plasma Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Plasma Therapeutics Consumption Share by End-Users in 2016
-
Figure Central China Plasma Therapeutics Consumption Share by End-Users in 2021
-
Figure Central China Plasma Therapeutics Consumption Share by End-Users in 2027
-
Table South China Plasma Therapeutics Consumption by Types from 2016 to 2027
-
Table South China Plasma Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure South China Plasma Therapeutics Consumption Share by Types in 2016
-
Figure South China Plasma Therapeutics Consumption Share by Types in 2021
-
Figure South China Plasma Therapeutics Consumption Share by Types in 2027
-
Table South China Plasma Therapeutics Consumption by End-Users from 2016 to 2027
-
Table South China Plasma Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure South China Plasma Therapeutics Consumption Share by End-Users in 2016
-
Figure South China Plasma Therapeutics Consumption Share by End-Users in 2021
-
Figure South China Plasma Therapeutics Consumption Share by End-Users in 2027
-
Table East China Plasma Therapeutics Consumption by Types from 2016 to 2027
-
Table East China Plasma Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure East China Plasma Therapeutics Consumption Share by Types in 2016
-
Figure East China Plasma Therapeutics Consumption Share by Types in 2021
-
Figure East China Plasma Therapeutics Consumption Share by Types in 2027
-
Table East China Plasma Therapeutics Consumption by End-Users from 2016 to 2027
-
Table East China Plasma Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure East China Plasma Therapeutics Consumption Share by End-Users in 2016
-
Figure East China Plasma Therapeutics Consumption Share by End-Users in 2021
-
Figure East China Plasma Therapeutics Consumption Share by End-Users in 2027
-
Table Northeast China Plasma Therapeutics Consumption by Types from 2016 to 2027
-
Table Northeast China Plasma Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Plasma Therapeutics Consumption Share by Types in 2016
-
Figure Northeast China Plasma Therapeutics Consumption Share by Types in 2021
-
Figure Northeast China Plasma Therapeutics Consumption Share by Types in 2027
-
Table Northeast China Plasma Therapeutics Consumption by End-Users from 2016 to 2027
-
Table Northeast China Plasma Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Plasma Therapeutics Consumption Share by End-Users in 2016
-
Figure Northeast China Plasma Therapeutics Consumption Share by End-Users in 2021
-
Figure Northeast China Plasma Therapeutics Consumption Share by End-Users in 2027
-
Table Southwest China Plasma Therapeutics Consumption by Types from 2016 to 2027
-
Table Southwest China Plasma Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Plasma Therapeutics Consumption Share by Types in 2016
-
Figure Southwest China Plasma Therapeutics Consumption Share by Types in 2021
-
Figure Southwest China Plasma Therapeutics Consumption Share by Types in 2027
-
Table Southwest China Plasma Therapeutics Consumption by End-Users from 2016 to 2027
-
Table Southwest China Plasma Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Plasma Therapeutics Consumption Share by End-Users in 2016
-
Figure Southwest China Plasma Therapeutics Consumption Share by End-Users in 2021
-
Figure Southwest China Plasma Therapeutics Consumption Share by End-Users in 2027
-
Table Northwest China Plasma Therapeutics Consumption by Types from 2016 to 2027
-
Table Northwest China Plasma Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Plasma Therapeutics Consumption Share by Types in 2016
-
Figure Northwest China Plasma Therapeutics Consumption Share by Types in 2021
-
Figure Northwest China Plasma Therapeutics Consumption Share by Types in 2027
-
Table Northwest China Plasma Therapeutics Consumption by End-Users from 2016 to 2027
-
Table Northwest China Plasma Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Plasma Therapeutics Consumption Share by End-Users in 2016
-
Figure Northwest China Plasma Therapeutics Consumption Share by End-Users in 2021
-
Figure Northwest China Plasma Therapeutics Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of China Biologic Products
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of China Biologic Products
-
Figure Sales and Growth Rate Analysis of China Biologic Products
-
Figure Revenue and Market Share Analysis of China Biologic Products
-
Table Product and Service Introduction of China Biologic Products
-
Table Company Profile and Development Status of BioDelivery Sciences
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioDelivery Sciences
-
Figure Sales and Growth Rate Analysis of BioDelivery Sciences
-
Figure Revenue and Market Share Analysis of BioDelivery Sciences
-
Table Product and Service Introduction of BioDelivery Sciences
-
Table Company Profile and Development Status of Grifols Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Grifols Therapeutics
-
Figure Sales and Growth Rate Analysis of Grifols Therapeutics
-
Figure Revenue and Market Share Analysis of Grifols Therapeutics
-
Table Product and Service Introduction of Grifols Therapeutics
-
Table Company Profile and Development Status of Octapharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Octapharma
-
Figure Sales and Growth Rate Analysis of Octapharma
-
Figure Revenue and Market Share Analysis of Octapharma
-
Table Product and Service Introduction of Octapharma
-
Table Company Profile and Development Status of Biotest Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biotest Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Biotest Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Biotest Pharmaceuticals
-
Table Product and Service Introduction of Biotest Pharmaceuticals
-
Table Company Profile and Development Status of Baxter
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Baxter
-
Figure Sales and Growth Rate Analysis of Baxter
-
Figure Revenue and Market Share Analysis of Baxter
-
Table Product and Service Introduction of Baxter
-
Table Company Profile and Development Status of ADMA Biologics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of ADMA Biologics
-
Figure Sales and Growth Rate Analysis of ADMA Biologics
-
Figure Revenue and Market Share Analysis of ADMA Biologics
-
Table Product and Service Introduction of ADMA Biologics
-
Table Company Profile and Development Status of CSL Behring
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of CSL Behring
-
Figure Sales and Growth Rate Analysis of CSL Behring
-
Figure Revenue and Market Share Analysis of CSL Behring
-
Table Product and Service Introduction of CSL Behring
-
Table Company Profile and Development Status of Biota Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biota Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Biota Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Biota Pharmaceuticals
-
Table Product and Service Introduction of Biota Pharmaceuticals
-
Table Company Profile and Development Status of Bio Products Laboratory
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bio Products Laboratory
-
Figure Sales and Growth Rate Analysis of Bio Products Laboratory
-
Figure Revenue and Market Share Analysis of Bio Products Laboratory
-
Table Product and Service Introduction of Bio Products Laboratory
-
Table Company Profile and Development Status of Amag Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amag Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Amag Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Amag Pharmaceuticals
-
Table Product and Service Introduction of Amag Pharmaceuticals
-
Table Company Profile and Development Status of Abeona Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abeona Therapeutics
-
Figure Sales and Growth Rate Analysis of Abeona Therapeutics
-
Figure Revenue and Market Share Analysis of Abeona Therapeutics
-
Table Product and Service Introduction of Abeona Therapeutics
-
Table Company Profile and Development Status of Antares Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Antares Pharma
-
Figure Sales and Growth Rate Analysis of Antares Pharma
-
Figure Revenue and Market Share Analysis of Antares Pharma
-
Table Product and Service Introduction of Antares Pharma
-

Chinese